Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Resolve Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Resolve Therapeutics

Resolve Therapeutics

Closed

US-based Resolve Therapeutics LLC develops biologic compounds for lupus treatment.

HQ
Kirkland, WA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Founded in St. Petersburg, United States, Resolve Therapeutics LLC is a biotechnology company dedicated to developing biologic compounds for the treatment of lupus. The company's core mission is to provide innovative and effective therapies for patients suffering from this chronic autoimmune disease. By focusing on biologic treatments, Resolve Therapeutics aims to improve the quality of life for lupus patients through advanced medical solutions.

Notable affiliated individuals and investors include experts in the field of biotechnology and healthcare, though specific names are not provided. Resolve Therapeutics has made significant strides in its research and development efforts, contributing to the broader understanding and treatment of lupus. The company's impact is measured by its commitment to advancing medical science and offering hope to those affected by lupus.

Resolve Therapeutics - Similar Companies

Resolvyx Pharmaceuticals logo

Resolvyx Pharmaceuticals

Resolys Bio logo

Resolys Bio

Resilience Therapeutics logo

Resilience Therapeutics

Solve Therapeutics logo

Solve Therapeutics

Therapyx logo

Therapyx

therapyxinc.com

Reset Therapeutics logo

Reset Therapeutics

Microbiome Therapeutics logo

Microbiome Therapeutics

Reset Pharmaceuticals logo

Reset Pharmaceuticals

LTZ Therapeutics logo

LTZ Therapeutics

Rise Therapeutics logo

Rise Therapeutics

Denali Therapeutics logo

Denali Therapeutics

Faze Medicines logo

Faze Medicines

fazemed.com

Nuon Therapeutics logo

Nuon Therapeutics

Receptor BioLogix logo

Receptor BioLogix

Logical Therapeutics logo

Logical Therapeutics

Resolve Therapeutics - Quick Facts

Who are Resolve Therapeutics' competitors?

Companies similar to Resolve Therapeutics include Resolvyx Pharmaceuticals, Resolys Bio, Resilience Therapeutics and Solve Therapeutics.

When was Resolve Therapeutics founded?

Resolve Therapeutics was founded in 2010.

Where is Resolve Therapeutics' headquarters located?

Resolve Therapeutics' headquarters is located in Kirkland, WA, US.

When was Resolve Therapeutics' last funding round?

Resolve Therapeutics' most recent funding round was for $5.8M (USD) in November 2012.

How much has Resolve Therapeutics raised to-date?

As of Nov 1, 2012, Resolve Therapeutics has raised a total of $8.9M (USD).

Resolve Therapeutics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Main Product
  • Biologic Compounds
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified